
Proniras
Operator of a clinical-stage biotechnology company intended for the development of novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system (CNS) disor...
Valuation
$17.5M
Latest known
Share Price
N/A
Total Raised
$11.2M
Last Round
N/A